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Abstract
 
The leading cause of mortality and morbidity in humans
with cystic fibrosis is lung disease. Advances in our under-
standing of the pathogenesis of the lung disease of cystic fi-
brosis, as well as development of innovative therapeutic in-
terventions, have been compromised by the lack of a natural
animal model. The utility of the 
 
CFTR
 
-knockout mouse in
studying the pathogenesis of cystic fibrosis has been limited
because of their failure, despite the presence of severe intes-
tinal disease, to develop lung disease. Herein, we describe
the phenotype of an inbred congenic strain of 
 
CFTR
 
-knock-
out mouse that develops spontaneous and progressive lung
disease of early onset. The major features of the lung disease
include failure of effective mucociliary transport, postbron-
chiolar over inflation of alveoli and parenchymal interstitial
thickening, with evidence of fibrosis and inflammatory cell
recruitment. We speculate that the basis for development of
lung disease in the congenic 
 
CFTR
 
-knockout mice is their
observed lack of a non-CFTR chloride channel normally
found in 
 
CFTR
 
-knockout mice of mixed genetic back-
ground. (
 
J. Clin. Invest.
 
 1997. 100:3060–3069.) Key words:
lung mechanics 
 
•
 
 ion transport 
 
•
 
 obstructive airway disease 
 
•
 
pulmonary fibrosis 
 
•
 
 chloride channels
 
Introduction
 
Lung disease remains the leading cause of severe illness and
death in patients with cystic fibrosis (CF),
 
1
 
 and the most com-
mon recessively inherited disorder in Caucasian populations
(1, 2). CF is caused (3) by mutations in the CF transmembrane
conductance regulator gene (
 
CFTR
 
). The protein product of
 
CFTR
 
 is a Cl
 
2
 
 channel, and the resultant inadequate Cl
 
2
 
 trans-
port in epithelia of CF patients is assumed to be the initiating
cause of the chronic pathological sequelae of CF (4). The in-
termediate steps between a failure of Cl
 
2
 
 transport and the de-
velopment of lung disease have not been completely eluci-
dated. Longitudinal studies of affected humans have provided
some insights into the possible pathogenesis of their lung dis-
ease (5–7), but progress has been hampered by the lack of any
natural animal model. The first knockout strain of mice lack-
ing functional CFTR (designated 
 
Cftr
 
m1UNC
 
) were produced at
the University of North Carolina
 
 
 
in 1992 (8, 9).
 
 
 
Unexpectedly,
these mice failed to develop lung pathology, even in adult-
hood, despite severe bowel disease (8, 9). 
Rozmahel et al. (10), using another strain of knockout mice
lacking CFTR (
 
Cftr
 
m1HSC
 
/
 
Cftr
 
m1HSC
 
), demonstrated that there
was a difference in severity of intestinal disease between CF
mice of different genetic backgrounds. These authors sug-
gested that modifier genes could be upregulated in CF, which
would directly or indirectly partially correct the abnormali-
ties of Na
 
1
 
 and Cl
 
2
 
 epithelial ion transport. These included a
non-CFTR Cl
 
2
 
 conductance gene, the activity of which could
compensate, in part, for the lack of intestinal CFTR. We hy-
pothesized that the mixed genetic background of the original
C
 
ftr
 
m1UNC
 
 strain could similarly influence the development of
lung pathology. To produce animals of a single genetic back-
ground (congenic), heterozygous mice from the original out-
bred colony (
 
Cftr
 
m1UNC
 
) were bred into a C57BL/6J back-
ground (C57BL/6J
 
 Cftr
 
m1UNC
 
/
 
Cftr
 
m1UNC
 
) by serial backcrossing.
CF mice are severely affected by intestinal disease, and the
majority die from intestinal obstruction during the 3-wk period
after weaning. As in our previous studies with CF mice, we
used a nutrient liquid diet to prolong survival (11). We ob-
served that the surviving congenic mice consistently develop
spontaneous and progressive lung disease. Lung histology was
examined at 21 d to 6 mo after birth by both light and electron
microscopy. Pulmonary function tests and measurements of
nasal potential difference (PD) were also performed.
 
Methods
 
Animals.
 
Animal housing conditions, diet, and tail clip analyses for
genotype have been reported in detail elsewhere (11). Heterozygous
 
Cftr
 
m1UNC
 
 
 
mice (courtesy of Dr. Beverly Koller, University of North
Carolina, Chapel Hill, NC) were bred into a C57BL/6J background
through backcrossing to wild type C57BL/6J mice (The Jackson Lab-
oratory, Bar Harbor, ME). Heterozygous mice were identified in
each generation by PCR, using primers specific for the endogenous
CFTR locus and for the mutant CFTR locus: Primer A (wild type)
5
 
9
 
CTGTAGTTGGCAAGCTTTGAC3
 
9
 
; Primer A (mutant) 5
 
9
 
ACA-
CTGCTCGAGGGCTAGCCTCTTC3
 
9
 
;
 
 
 
Primer B (wild type and mu-
tant) 5
 
9
 
CAGTGAAGCTGAGACTGTGAGCTT3
 
9
 
. The degree of
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1. 
 
Abbreviations used in this paper: 
 
CF, cystic fibrosis; C
 
rs
 
, respiratory
system compliance; FVC, forced vital capacity; PAS, Periodic Acid-
Schiff; PD, potential difference; R
 
rs
 
, respiratory system resistance;
TLC, total lung capacity; t
 
rs, 
 
flow–volume relationship.
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C57BL/6J genetic background was determined through microsatellite
marker typing in generations 2, 3, and 4. A total of 66 informative mi-
crosatellite markers, distributed over the entire genome, were tested.
In each generation, the mouse with the highest degree of B6 genetic
background was chosen for subsequent breeding. In generation 4,
three out of five pups showed 100% homozygocity for B6 alleles.
Breeding was then continued for another 14 generations.
 
Microsatellite typing. 
 
High molecular weight genomic DNA was
prepared from tail tissue through a modification of the salting out
procedure (12). Briefly, tails (2 cm) were digested overnight at 55
 
8
 
C
with proteinase K (0.5 mg/ml). Proteins were then precipitated with a
saturated NaCl solution followed by centrifugation at 13,000 rpm for
10 min. DNA was ethanol precipitated and redissolved in Tris-EDTA
buffer. PCR reactions were performed as described by O’Brien et al.
(13). Primers were used under standardized conditions: 2mM MgCl
 
2
 
,
200 
 
m
 
M dNTP, 100 nM primers, 20 ng genomic DNA, and 1 U Taq
polymerase. The reverse primer was 5
 
9
 
 end-labeled with 
 
g
 
[
 
32
 
P]ATP
using T4 polynucleotide kinase. 5 nmol of the labeled primers were
added to the PCR reaction. Thermal cycling was carried out for 35
cycles (1 min, 94
 
8
 
C; 1 min, 50
 
8
 
C; 1 min, 72
 
8
 
C). PCR products were di-
luted in 100% formamide and denatured for 2 min at 95
 
8
 
C. Electro-
phoresis was performed in 6% (wt/vol) polyacrilamide gels con-
taining 8 M urea. Gels were dried for autoradiographic analysis
(BIOMAX film).
 
Screening for infection. 
 
Immediately before animals were exam-
ined histologically, a routine serology surveillance was performed on
the entire colony using sentinel mice (CD-1 strain) which had been
placed in open cages in the rooms for three months and then exsan-
guinated under general anesthesia. The sera from these animals was
frozen and shipped to the University of Missouri Research Animal
Diagnostics Laboratory (Columbia, MO) to be screened for rodent
viral pathogens (mouse hepatitis, Sendai, mouse pneumonia, respira-
tory enteric orphan, ectromelia, Theiler’s murine encephalitis, mouse
adenoviruses 1 and 2, lymphocytic choriomeningitis, infant mouse en-
zootic diarrhea, polyoma, and parvoviruses), 
 
Carbacillus
 
 and 
 
Myco-
plasma pulmonis
 
. These animals were immediately adjacent to an-
other group of sentinel mice that were maintained under the same
conditions for a further 6 wk. Half of these animals were screened
as above, as were animals from all other mouse rooms (including im-
muno-compromised colonies) in our animal facility. The remaining
sentinel mice, four congenic C57BL/6J CF mice and four C57BL/6J
heterozygotic CF mouse breeders, were submitted alive to the On-
tario Veterinary College Department of Pathology, University of
Guelph (Guelph, Ontario, Canada) for histopathological screening of
kidneys, lungs, heart, spleen, pancreas, salivary glands, jejunum, il-
eum, colon, brain, seminal vesicles, thymus, and lymph nodes. Lung
and jejunal tissue were cultured for aerobic and anaerobic bacteria.
 
Preparation of samples for microscopy. 
 
18 C57BL/6J 
 
Cftr
 
m1UNC
 
/
 
Cftr
 
m1UNC
 
 mice were studied. Nine heterozygous 
 
Cftr
 
m1UNC
 
 
 
mice and
nine wild-type C57BL/6J age-matched were used as controls. Five of
the C57BL/6J age-matched controls were maintained on the same liq-
uid diet, and four were fed solid chow. Animals were anesthetized
with 30 mg/kg intraperitoneal chloral hydrate (Allan and Hanbury,
Toronto, Canada). The chest was opened and the trachea exposed. In
the animals used for electron microscopic examination, fixative was
instilled into the trachea, through a needle, until the lungs inflated
and there was back flow through the nares. The trachea was then
quickly ligated. The fixative used was 1% glutaraldehyde (vol/vol)
and 4% (vol/vol) paraformaldehyde in 0.1 M phosphate buffer. The
lungs were then excised and submerged in fixative. The seven lungs
used for light microscopic examination were perfused with 10% (vol/
vol) neutral buffered formalin, then fixed for 3 d under 5 cm H
 
2
 
O
pressure. The lungs were then embedded in paraffin for sectioning
and staining. For the study of sinuses, heads from animals in all three
groups were fixed in 10% (vol/vol) neutral buffered formalin, then
decalcified in 8% (vol/vol) formic acid for 3 d before being embedded
in paraffin for sectioning and staining. Sections were stained with he-
matoxylin and eosin, PAS, or Masson’s trichrome.
Both scanning and transmission electron microscopy (ScEM and
TrEM) were performed. The lungs were fixed for 4 h, washed with
buffer, and post fixed with phosphate-buffered O
 
2
 
O
 
4
 
. Samples were
dehydrated in an ascending series of ethanols. ScEM samples were
then critical point dried and rendered conductive with a thin layer of
gold. TrEM samples were embedded in epon-araldite via propylene
oxide. Ultrathin sections exhibiting a pale gold interference color
were mounted on grids and stained with uranyl acetate and lead ci-
trate. These specimens were then examined and photographed. Digi-
tal images were obtained for both sets of samples and morphometry
performed using an image analysis program (NIH image 1.59; Na-
tional Institutes of Health, Bethesda, MD). A minimum of 25 fields
were analyzed, for each of 3 animals, to determine the percentage of
terminal bronchiolar cells which were of a nonciliated cell type and
the interalveolar interstitial macrophage and fibroblast density per
mm
 
2
 
. Results are shown as mean
 
6
 
SD, and statistical comparisons at
single time points were made using Student’s 
 
t
 
 test.
 
Pulmonary function tests. 
 
Five C57BL/6J 
 
Cftr
 
m1UNC
 
/
 
Cftr
 
m1UNC
 
 mice
were anesthetized as above and tracheotomized with a 4–French An-
giocath. 21 age- (6–9 mo) and sex-matched wild-type control C57BL/
6J mice, and five heterozygous 
 
Cftr
 
m1UNC
 
 
 
mice, aged 3–4 mo with
body weights intermediate between the other two groups, were simi-
larly anesthetized and used as controls. The animals were paralyzed
with 0.1 mg/kg intraperitoneal pancuronium (Pavulon; Organon,
Scarborough, Ontario, Canada), placed in a plethysmographic box
(300 cm
 
3
 
), and ventilated with an infant ventilator (Model IV_100B;
Sechrist Industries, Inc., Anaheim, CA) at a tidal volume of 0.25
 
6
 
0.01
ml (mean
 
6
 
SEM) with 100% oxygen. Changes in plethysmography
box flow and volume were recorded using a pneumotachograph with
a dead space of 0.3 ml (8430B; Hans Rudolf, Inc., Kansas City, MO),
connected to a pressure transducer (Validyne MP 45; Validyne Engi-
neering Corp., Northridge, CA) with a linear range of 0–2 cm H
 
2
 
O).
Airway pressure at the mouth was measured using a second pressure
transducer (Validyne MP 45; Validyne Engineering Corp.) with a lin-
ear range of 0–30 cm H
 
2
 
O. Signals from the pressure transducers
were passed via a 12 bit A-D board (Transduction, Mississauga, On-
tario, Canada), to a computer for analysis using the Anadat computer
program software (Baker Instruments, Concord, Ontario). Weight,
respiratory system compliance (C
 
rs
 
), resistance (R
 
rs
 
), and forced vital
capacity (FVC) were measured for all animals. Maximal flows through
endotracheal tubes alone were measured for the various deflation
pressures. The resistance of the circuit was found to be flow-depen-
dent, ranging from 2–5 cm H
 
2
 
O
 
2
 
1
 
/ml/s. A 1.5-liter perspex box was
used to contain the negative pressure, generated and regulated from
wall source. Three computer-activated solenoids (Cole Palmer In-
struments, Vernon Hills, IL) were placed in the expiratory limb of the
circuit. When activated at full inspiration the first solenoid occluded
the inspiratory/expiratory line of the ventilator. The second solenoid
opened the circuit to the negative pressure box, allowing forced defla-
tion. The third solenoid opened the circuit to atmospheric pressure,
allowing relaxed deflation.
The forced deflation (FD) technique allows the examination of
maximal expiratory maneuvers in subjects unable to perform a volun-
tary forced exhalation (14). This method standardizes for volume by
inflating the lungs to total lung capacity (TLC). The intubated airway
was then rapidly deflated to residual volume (RV) by the generation
of a negative pressure gradient. Flows obtained at the various airway
opening pressures were compared according to Fry et al. (15), at iso-
volume points of 50, 25, and 10% of forced vital capacity (MEF50%,
MEF25%, and MEF10%, respectively). The maximal expired volume
obtained from the FD maneuver was termed the FVC, and served as
the reference volume for the calculation and comparison of flow rates
at isovolume points. The curves were anchored at RV. Passive airway
occlusion was also performed. It was assumed that with complete res-
piratory muscle paralysis there would be equilibrium of the pressure
throughout the airways, and that airway opening reflected the elastic
recoil pressure of the respiratory system. Pressure was measured dur-
ing the occlusion, and the resultant flow–volume relationship (t
 
rs
 
)
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during passive expiration was examined. Extrapolation of the flow–
volume profile to zero flow allowed the estimation of the total vol-
ume that would be exhaled, if the mouse emptied to the elastic equi-
librium volume (EEV) of the respiratory system. Compliance (C
 
rs
 
)
was calculated from the ratio of the volume above EEV at which the
occlusion was made, to the end-inspiratory recoil pressure at this vol-
ume. Resistance (R
 
rs
 
) was calculated by relating the time constant
(t
 
rs
 
) to the measured compliance (R
 
rs 
 
5 
 
t
 
rs
 
/C
 
rs
 
), assuming a linear rela-
tionship over the expired volume range. Airway occlusions were per-
formed at the inflated lung volume of TLC. This was achieved by in-
creasing the flow through the ventilator to give a ventilator pressure
of 40 cm H
 
2
 
O, and an airway pressure of 18
 
6
 
0.2 cm H
 
2
 
O
(mean
 
6
 
SEM). TLC was sustained for 3 s before the occlusion of the
airway and relaxed deflation to atmospheric pressure, or the applica-
tion of a forced deflation. Airway opening pressures were initially
zero (airway open to atmospheric pressure), and then decreased from
 
2
 
6 to 
 
2
 
12 cm H
 
2
 
O at intervals of 
 
2
 
2 cm H
 
2
 
O. Maximal flows
through endotracheal tubes alone were measured for the various de-
flation pressures. The resistance of the circuit was found to be flow
dependent, ranging from 2–5 cm H
 
2
 
O
 
2
 
1/ml/s
 
. A one-way ANOVA was
used for group comparisons of weight, flow–volume, compliance, and
resistance, with a significance level of
 
 P 
 
, 
 
0.05. The Student Newman
Keul’s adjustment was used to determine differences among groups.
 
Nasal potential difference measurements. 
 
Three groups of ani-
mals were compared. The groups consisted of age-matched C57BL/6J
wild type (
 
n
 
 5 
 
27), C56BL/6J 
 
Cftr
 
m1UNC
 
/
 
Cftr
 
m1UNC
 
 (
 
n
 
 5 
 
11), and
 
Cftr
 
m1UNC
 
 mice of mixed genetic background (
 
n
 
 5 
 
7).
 
 
 
Methods were
adapted from the clinical use of this technique in CF patients (16).
The mice were anesthetized as described above, and a cannula
(PE10) containing Ringers lactate was inserted 0.5 cm into the right
nares. Ringers lactate was continuously perfused through this cannula
at a rate of 1 ml/h, via a 50-ml syringe attached to an infusion pump.
The syringe was connected to a calomel electrode in 3 M KCl solu-
tion, and via an agar bridge to a voltmeter and recorder. A subcuta-
neous needle positioned on the abdomen was connected via an agar
bridge to a second calomel electrode, which served as the reference
electrode. Experimental reagents and drugs were administered
through a tube that formed a sleeve surrounding the nasal catheter,
and which ended 0.5 cm from the catheter tip. All solutions were
warmed to 37
 
8
 
C before use. A steady PD measurement was obtained
within a few minutes, at which time Ringers lactate solution contain-
ing 100 
 
m
 
M amiloride (Sigma Chemical Co., St. Louis, MO) was per-
fused through the sleeve cannula at 3 ml/h, while the flow of Ringers
lactate was slowed to 0.3 ml/h. The response to amiloride was moni-
tored for 3–5 min. After the amiloride perfusion, the solution was
changed to a Cl
 
2
 
-free solution, in which Cl
 
2
 
 had been replaced by
gluconate, with amiloride to provide a driving force for apical Cl
 
2
 
conductance. The perfusion with Ringers lactate was discontinued
during this manipulation. Following this, the activity of the Ca
 
2
 
1
 
-acti-
vated Cl
 
2
 
 channel in the apical membrane was assessed by the addi-
tion of 100 
 
m
 
M uridine triphosphate (UTP; Boehringer Mannheim,
Laval, Quebec, Canada), an agonist of phospholipase C and IP
 
3
 
-medi-
ated Ca21 release from intracellular stores. Data were tabulated and
expressed as mean6SEM.
Results
Disease severity in congenic mice. Fewer congenic CF mice
(C57BL/6J Cftrm1UNC/Cftrm1UNC) survived the perinatal period
than did CF mice of a mixed genetic background (Cftrm1UNC).
Survival of UNC CF animals at 20 d was 15.5% (of all live
births) in the outbred animals, and only 6.4% in the congenic
C57BL/6J CF animals, indicating a more severe phenotype.
Deaths were usually observed within 3 d of birth in both
groups and, when autopsy was possible, the cause of death was
intestinal disease. Both the colon and the distal ileum were in-
volved.
Pathology–light microscopy. No abnormal histology was
detected in the sinuses or tracheas or large bronchi of any ani-
mals (not shown). However, whole lung sections demonstrated
marked and widespread pathology in the C57BL/6J CF lungs
(Fig. 1, E and F). Lesions were patchy, with areas of marked
acinar dilatation consistent with obstructive small airway dis-
ease, and also areas of interstitial thickening. Interstitial dis-
ease could be detected as early as 30 d of age. In the C57BL/6J
CF animals, there was an accumulation of inflammatory cells
and connective tissue in the alveolar wall, resulting in alveolar
wall thickening and loss of alveolar architecture even at this
early age. These pathological changes did not represent an ho-
mogeneous process. Patchy areas of abnormality were scat-
tered throughout the lungs. The pathological changes were
more severe in older animals and, by three months, sections
stained with Masson’s trichrome revealed distinct areas of en-
hanced staining in the alveolar interstitium, which had further
increased in intensity by 6 mo of age (not shown), indicative of
an increased deposition of collagen and other fibrillar mate-
rial. Positive staining with Periodic Acid-Schiff (PAS), for
acidic mucopolysaccharides, was seen in material lining nor-
mal C57BL/6J and UNC CF airways (Fig. 1, B and D). This
was markedly increased in extent and intensity in the airways
of C57BL/6J CF mice, and intracytoplasmic staining was also
evident in nonciliated cells lining the airways (Fig. 1 F).
Lung pathology; electron microscopy of the airways. Scan-
ning electron microscopy of lungs from C57BL/6J CF mice 6 mo
after birth showed many bronchiolar surfaces covered with a
thick layer of a material (Fig. 2 E), which was also evident in
alveoli (Fig. 2 F), but not in control C57BL/6J mice (Fig. 2, A
and B), or UNC CF mice (Fig. 2, C and D). Morphometric
analysis revealed clear differences in airway epithelial cell
composition between controls and C57BL/6J CF mice (Table
I). The C57BL/6J CF mice had an age-dependent increase in
the relative proportion of nonciliated cells, which were as-
sumed to be secretory cells. At 1 mo, C57BL/6J CF mice had
proportionally less nonciliated cells than did animals in either
control group (P , 0.01). The 3- and 6-mo C57BL/6J CF mice
had a significant increase (P , 0.005) in the proportion of non-
ciliated airway cells (56–60%) compared with control animals
(37–42%). Nonciliated cell morphology also differed between
the three groups of animals (Fig. 3, A–C). In the 1-mo C57BL/
6J CF mice, the majority of the nonciliated cells contained few
if any secretory granules, few mitochondria and only occa-
sional osmiophilic droplets adjacent to the apical membrane.
By 3 mo of age, the most striking change in the nonciliated cell
cytoplasm of affected animals was a proliferation of smooth
endoplasmic reticulum, as well as an increase in the number of
secretory granules. By 6 mo, the nonciliated cell cytoplasm
contained numerous secretory granules, with lipid-like mate-
rial sequestered in the smooth endoplasmic reticulum. This
was in marked contrast to C57BL/6J control animal noncili-
ated cell morphology, in which secretory granules were fre-
quent at 1 mo, and neither proliferation nor sequestration of
material within the smooth endoplasmic reticulum occurred in
older C57BL/6J control animals. The findings in UNC CF mice
(not shown) were not different from C57BL/6J control ani-
mals.
Lung pathology; electron microscopy of the alveolar re-
gion. Compared with C57BL/6J control mice (Fig. 4 A), the
interalveolar interstitium of the C57BL/6J CF mice contained
an increase in fibroblasts containing lipid-like material by 6 mo
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of age, and the increased deposition of fibrillar material sug-
gested by light microscopy was clearly seen on transmission
electron microscopy (Fig. 4 B). The fibroblastic nature of the
cells containing the lipid-like material was confirmed using an-
tibodies to a mesenchymal cell-specific cytoskeletal protein, vi-
mentin (not shown). The interalveolar interstitium of the UNC
CF mice (not shown) was no different to that of the C57BL/6J
CF mice. Morphometric analysis of interalveolar interstitial ar-
eas of C57BL/6J CF mice (Table I) demonstrated a significant
increase in granulocytes at 1 mo of age (P , 0.005). Granulo-
cyte numbers remained above control values at 3 and 6 mo,
but were not statistically significant. There was also a signifi-
cant increase (P , 0.005) in interstitial macrophages and fibro-
blasts by 3 mo of age, with a significant increase (P , 0.005)
still present at 6 mo (Table I) in C57BL/6J CF mice. Control
animals had an increase in interstitial fibroblasts with age, but
this was of a lesser degree than in C57BL/6J CF mice. C57BL/6J
CF mice had type I pneumocytes with apparently normal
morphology, in contrast to their type II pneumocytes which
were clearly abnormal (Fig. 4 C). The type II pneumocytes in
C57BL/6J CF mice had an increased number of mitochondria
and fewer surfactant-containing lamellar bodies, which was
most evident in older animals.
Bacterial colonization. No viral, mycoplasmal, fungal, or
other respiratory pathogens were identified in any of the 50
animals tested by serology. Histological examination of those
control animals sharing housing space with the colony of CF
mice, revealed no pathological lesions in any of the organs ex-
amined. Lung cultures of the CF mice showed no growth of
Pseudomonas, Burkholderia, or Haemophilus species or of co-
agulase-positive Staphylococcus aureus, the organisms most
commonly associated with human CF lung disease . A scant
growth of non-pathogenic Streptococcus viridans was found in
the lungs of three of the five CF mice undergoing autopsy, but
Figure 1. Lung morphology. (A) 
Low power view of control C57BL/
6J lung at six months. Bar 5 0.25 
mm. (C) Low power view of control 
Cftrm1UNC lung at 6 mo, showing 
normal architecture. Bar 5 0.25 
mm. (E) Low power view of 6 mo 
C57BL/6J Cftrm1UNC/Cftrm1UNC lung 
showing enlarged acini and areas of 
interstitial thickening (arrowheads). 
Bar 5 0.25 mm. Staining with PAS 
to show material consistent with 
acid mucopolysaccharide on the air-
way surface (arrows) and in secre-
tory cells (arrowheads) of control 
C57BL/6J (B), Cftrm1UNC (D) and 
C57BL/6J Cftrm1UNC/Cftrm1UNC (F) 
lungs at 6 mo. Bars, 24 mm.
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these animals did not demonstrate any more severe lung pa-
thology. No organisms were isolated from the lungs of the con-
trol animals.
Pulmonary function tests. Although total respiratory sys-
tem compliance and resistance have been measured in mice,
such global measurements of lung function may be too insensi-
tive to detect early small airway pathology (17–19). In an at-
tempt to enhance the sensitivity of testing in mice, we adapted
two methods used to detect small airway disease in infants
(20): the single breath passive occlusion, and the forced nega-
tive pressure deflation techniques (14, 20, 21). The C57BL/6J
CF mice were significantly (P , 0.05) growth restricted
(21.7462.34 g; mean6SEM) relative to their age-matched
controls (33.9864.86 g; mean6SEM). UNC CF mice had in-
termediate weights (27.2862.99 g; mean6SEM). Therefore, to
correct for these size differences, we corrected lung mechanics
measurements, when appropriate, by dividing by body weight.
The respiratory system compliance, per kilogram body weight,
was significantly greater in the C57BL/6J CF mice (P , 0.05)
than in either control groups (Fig. 5 A). The forced vital capac-
Figure 2. Scanning electron micros-
copy. Micrographs of control 
C57BL/6J (A and B), Cftrm1UNC (C 
and D) and C57BL/6J Cftrm1UNC/
Cftrm1UNC (E and F) lungs at 6 mo to 
show the airway epithelial surface 
(A, C, and E) and alveoli (B, D, and 
F). In the lungs from Cftrm1UNC/
Cftrm1UNC mice, a thick layer of ma-
terial is seen covering the airway ep-
ithelium (E), which extends to the 
alveoli (F). Bars, 10 mm.
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ity (FVC), a measure of lung volume, was significantly (P ,
0.05) less, per kilogram body weight, in the UNC CF mice
compared with C57BL/6J control of CF mice (Fig. 5 B). The
mean FVC was increased z 20% in C57BL/6J CF mice com-
pared with C57BL/6J control animals, consistent with air trap-
ping, but this did not achieve statistical significance. There was
no significant difference for respiratory system resistance (Fig.
5 C). Because airway resistance declines with increased size,
this parameter was not corrected for weight. Respiratory sys-
tem resistance is a measurement dominated by the resistance
of the large airways. In an attempt to assess the condition of
the peripheral airways, we measured the maximum expiratory
flow at 50, 25 and 10% of the FVC. Though there was an ap-
parent trend towards a reduction in flows at 25 and 10% of the
FVC in C57BL/6J CF and UNC CF animals compared with
C57BL/6J control animals, consistent with narrower periph-
eral airways, statistical significance was not achieved.
Nasal potential difference. To determine whether there may
be differences in respiratory epithelial ion transport associated
with the development of airway disease in these Cftrm1UNC/
Cftrm1UNC animals, the bioelectrical properties of their nasal
mucosa were compared with measurements obtained in either
their non-CF siblings or Cftrm1UNC mice, neither of which had
lung disease. Typical nasal PD profiles of wild-type and con-
genic CF animals are shown in Fig. 6 A, and aggregate data in
Fig. 6 B. The congenic CF mice exhibited a significantly ele-
vated negative basal PD profile, when compared with the wild
type (P , 0.002), and lacked the normal PD response to the
imposition of a luminally directed Cl2 gradient when exposed
to a Cl2-free solution (P , 0.05). This feature is consistent
with the absence of a Cl2 conductance, namely CFTR, from the
apical surface of the nasal epithelium (22). Surprisingly, there
was no significant difference in the drop in PD in response to
amiloride between the wild type and the congenic CF mice. In
Figure 3. Transmission electron mi-
croscopy. Micrographs of airway 
nonciliated cells in control C57BL/
6J lung at 6 mo (A), or C57BL/6J 
Cftrm1UNC/Cftrm1UNC lungs at 3 (B) 
and 6 (C) mo to show the relative in-
crease in the nonciliated cell popula-
tion. All bars, 1 mm.
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previous studies with mice and humans, it had been found that
the elevated basal PD characteristic of CF epithelia was ac-
counted for by the augmentation of an amiloride-sensitive so-
dium conductance (24). We suggest that the elevated negative
basal PD seen in the C57BL/6J Cftrm1UNC/Cftrm1UNC mice may
be due to the activity of apical sodium transport pathways that
are not amiloride-inhibitable, as has been previously described in
bovine tracheal epithelium (23). Furthermore, C57BL/6J wild
type and C57BL/6J Cftrm1UNC/Cftrm1UNC mice failed to show a
PD response to the administration of UTP, an agonist of P2U
type purinergic receptors, coupled to IP3-mediated Ca21 re-
lease from intracellular stores. These results contrast with those
seen in the Cftrm1UNC/Cftrm1UNC mice, in which UTP evoked a
large change in nasal PD in the present and previously pub-
lished (24) studies, a response thought to represent stimulation
of apically localized Ca21-activated Cl2 channels. Hence, our
results suggest that the C57BL/6J mice either lack this conduc-
tance path, or that it can not be activated properly. Alterna-
tively, it is conceivable that the inability to detect a change in
negative PD with UTP is secondary to the persistence of a ba-
sally-active, amiloride-insensitive Na1 absorptive path.
Discussion 
For technical reasons, the production of knockout mice is lim-
ited to the strain from which the embryonic stem cell lines are
derived, and subsequent breeding frequently involves the use
of mice of different strains to increase viability. Unfortunately,
the resulting progeny carry a mixed genetic background that
may vary both over time and between breeding colonies. It is
clear, from this study and previously published (10) studies,
that disease severity in CF is genetically determined by addi-
tional modifier loci. As in humans with CF, C57BL/6J
Cftrm1UNC/Cftrm1UNC mice develop severe peripheral lung in-
jury. As significant macroscopic and microscopic structural dif-
ferences exist between normal mouse and human lungs, some
differences in pathology of mouse and human CF lung disease
must be expected on these grounds alone. Humans and labora-
tory mice with CF are also exposed to very different environ-
ments. In the human, the characteristic airway changes are of
epithelial metaplasia, inflammatory infiltrate, bronchiectasis,
and mucopurulent plugging (25, 26). Given the high incidence
of acute and chronic infections in the human population, it is
difficult to know the degree to which these changes are sec-
ondary to infection, or how similar the morphology of the hu-
man airway would be to that seen in the mouse in the apparent
absence of severe respiratory pathogens. Despite these reser-
vations, human and mouse CF lungs do share a number of
characteristics.
Histological changes in CF mouse lungs were consistently
observed, and were obvious even in the lungs of animals as
young as 30 d. Low power views, using light microscopy,
showed that the congenic animals develop acinar and alveolar
hyperinflation consistent with obstructive small airway dis-
ease, which is a characteristic and early feature of human CF
(25, 26). In young human patients with CF, pulmonary func-
tion testing has shown small airway disease to be present even
before there is any evidence of acinar hyperinflation (7). This
hyperinflation in the mouse may, as in the human (25), be at-
tributable to a failure of mucociliary transport, with a build up
of material with characteristics of an acid mucopolysaccharide
in the distal airways, causing a ball valve obstruction. That a
similar pattern of obstruction occurs in the CF mouse lung was
suggested by our scanning EM observations. Despite attempts
to increase the sensitivity of pulmonary function tests for as-
sessment of distal airways, inherent limitations of methodol-
ogy did not allow us to confirm flow limitation in distal airways.
The observed increase in static compliance (reduced recoil) of
the CF mouse lungs is also consistent with the increase in
weight-corrected FVC and the histological changes, and is
seen in other situations in which there is over distension of
acini (27).
The material accumulating in the airways of CF mice has
the characteristics of an acid mucopolysaccharide, in that it
stains with PAS (12, 13). As yet, we do not have sufficient in-
formation to identify which cell type is the source of this mate-
rial. PAS-positive material is found in the matrix immediately
adjacent to nonciliated cells in normal lungs of several species,
and not within the cell (28). In the CF mouse lung, cells con-
taining PAS-positive material were found in nonciliated air-
way epithelial cells. Whether this represents an adaptation of
the normal resident nonciliated (Clara) cell population, or the
appearance of cells with a different lineage, can not be deter-
mined from the studies presented here. The Clara cell arises
from differentiation of fetal glycoprotein-secreting cells, as do
mucus-secreting cells (29), which is of potential relevance
given the recent suggestion that CFTR may play a regulatory
role in the development of secretory airway cells (30).
Foci of fibrosis are seen at autopsy of human patients with
CF, as was also seen in the congenic CF mice (12, 13). The pa-
renchymal interstitial disease is, however, an early and rela-
Table I. Morphometric Analyses of Lungs from Control 
C57BL/6J, Cftrm1UNC and C57BL/6J Cftrm1UNC/Cftrm1UNC mice
Percent nonciliated cells in bronchiole
C57BL/6J Cftrm1UNC
C57BL/6J
Cftrm1UNC/Cftrm1UNC
1 mo 45.468.2 1 mo 43.8610.2 1 mo 33.069.3
3 mo 40.668.2 3 mo 40.769.9 3 mo 56.6610.8
6 mo 37.765.9 6 mo 41.268.3 6 mo 60.368.9
Interstitial macrophages/mm2
C57BL/6J Cftrm1UNC
C57BL/6J
Cftrm1UNC/Cftrm1UNC
1 mo 4.161.3 1 mo 4.961.3 1 mo 3.760.6
3 mo 4.360.7 3 mo 4.662.0 3 mo 18.064.3
6 mo 5.361.2 6 mo 4.861.6 6 mo 21.363.1
Interstitial fibroblasts/mm2
C57BL/6J Cftrm1UNC
C57BL/6J
Cftrm1UNC/Cftrm1UNC
1 mo 6.261.8 1 mo 6.062.2 1 mo 6.461.4
3 mo 10.364.2 3 mo 9.462.8 3 mo 31.765.1
6 mo 19.765.2 6 mo 21.266.9 6 mo 79.068.7
Granulocytes/mm2
C57BL/6J Cftrm1UNC
C57BL/6J
Cftrm1UNC/Cftrm1UNC
1 mo 3.161.1 1 mo 3.561.4 1 mo 14.262.9
3 mo 2.860.8 3 mo 3.361.8 3 mo 8.961.6
6 mo 3.760.6 6 mo 4.061.6 6 mo 8.162.4
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tively larger component of the lung disease in the congenic CF
mouse lung than in the human. A degree of inflammatory cell
influx into the lungs of humans with CF is now recognized as
an early process, from the results of recent clinical studies of
bronchiolar lavage fluid samples from very young children
with CF (5, 6). The young congenic CF mice also had increased
granulocyctes, as well as fibroblast infiltration and deposition
of fibrillar matrix proteins into the interstitium by 21 d of age.
Phenotypic differences in pulmonary interstitial fibroblast
populations, distinguishable by their lectin-binding character-
istics, may be critical determinants of lung growth and lung in-
jury (31, 32). Lipid-containing fibroblasts, as seen in the lungs
of the congenic CF mice, have been reported by others to be
Thy 1 positive, and to secrete more collagen than fibronectin,
in contrast to a Thy 1 negative population that secretes more
Figure 4. Characteristics of lung in-
terstitium. Interstitial areas (*) of 
control C57BL/6J (A) or C57BL/6J 
Cftrm1UNC/Cftrm1UNC lungs (B and C) 
at 6 mo. In the C57BL/6J Cftrm1UNC/
Cftrm1UNC lungs, there are fibro-
blasts containing large lipid-ladened 
vacuoles, and a marked increase in 
fibrillar matrix protein (B). Type II 
pneumocytes (P) also had a mark-
edly abnormal appearance in the 
C57BL/6J Cftrm1UNC/Cftrm1UNC lungs 
(C). Bars are 0.5 mm (A and B) or 1 
mm (C).
Figure 5. Pulmonary function tests of C57BL/6J, C57BL/6J 
Cftrm1UNC/Cftrm1UNC (C57BL/6J-CF) and Cftrm1UNC/Cftrm1UNC (UNC-
CF) mice. Box plots of (A) weight-corrected total respiratory system 
compliance (Crs); (B) weight-corrected forced vital capacity (FVC); 
(C) total respiratory system resistance (Rrs) and (D) expiratory flow 
measurements at airway opening pressures of 28 cm H2O. Upper and 
lower boundaries of the box represent the 75th and 25th percentiles, 
respectively, with the upper and lower error bars representing the 
90th and 10th percentiles, respectively. Within the box the solid line 
represents the median, while the interrupted line represents the 
mean. Outlying points are shown as open circles. § 5 P , 0.05.
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fibronectin than collagen (33). This is consistent with the find-
ing of increased lipid-containing fibroblasts in regions with
increased fibrillar matrix protein deposition. Type II pneu-
mocyte injury, as seen in the congenic CF model, is not a char-
acteristic feature of human CF lung disease.
The failure of the Cftrm1UNC mice, of mixed genetic back-
ground, to develop lung disease has been attributed to the vig-
orous activity of alternate Cl2 channels in their airway epithe-
lium (26). In the present study, we observed the ion transport
properties of the nasal epithelium of C57BL/6 mice to be dif-
ferent from those previously reported for Cftrm1UNC/Cftrm1UNC
mice. The purinergic receptor agonist, UTP, failed to activate
a change in PD in the C57BL/6J Cftrm1UNC/Cftrm1UNC mice in
contrast to the results observed with the Cftrm1UNC/Cftrm1UNC
mice (34). This supports the hypothesis that the severely af-
fected C57BL/6J Cftrm1UNC/Cftrm1UNC mice lack, or fail to acti-
vate, an alternative Cl- conductance path. Hence, we speculate
that the combination of an heritable absence of an UTP-acti-
vated Cl2 channel with an experimentally engineered lack of
CFTR could account for the development of lung disease in
the congenic CFTR-knockout mice. Clearly, this speculation is
predicated on the assumption that the ion transport pathways
monitored in the nasal epithelium are representative of ion
transport events occurring in the lower airways. The relation-
ship between this loss of Cl2 conductance and the develop-
ment of lung disease has not been addressed in this study, but
others have postulated that the Cl2 ion plays a role in the bac-
tericidal capacity of the surface fluid bathing the airway epi-
thelium, as well as in the rheology of its mucus layer (35).
Alternatively, there may be a variation in the nature or prop-
erties of the Na1 channels which mediate absorption across the
airway epithelia of C57BL/6J mice. Our results indicate that
there may be Na1 channels (36) other than the typical amilo-
ride-sensitive epithelial Na1 channel (ENaC), which predomi-
nate in these mice to cause a high negative nasal PD. Clearly,
the activity of these channels may modulate the composition
of the fluid bathing the airway epithelium of the C57BL/6J
Cftrm1UNC/Cftrm1UNC mice.
There is a widely held, though still contentious, view that
bacterial colonization with unusual organisms, particularly
with Pseudomonas aeruginosa, of the airways of CF patients
results in the development of significant lung disease. The ob-
servation that children under 6 mo of age, several of whom
demonstrated no evidence of bacterial colonization, had an in-
crease in polymorphonuclear cell count and increased free
elastase activity in their bronchoalveolar lavage fluid calls an
obligatory role for infection into question (2). The congenic
CF mouse model also developed a progressive inflammatory
disease with no pathogenic organisms having been detected. It
is never possible to completely exclude the presence of patho-
genic infectious agents, despite repeatedly negative cultures
and serology, and we can not absolutely exclude an etiological
role for some undetected pathogen. However, it will still be of
future interest to challenge the congenic CF mice with respira-
tory pathogens, to determine if the morphologic changes seen
in their lungs, particularly the airway epithelium, are modified
to a pattern more consistent with human disease.
While there are some pathological differences in the CF
lung diseases of mice and humans, we anticipate that the con-
genic CF mouse will prove to be a valuable tool with which to
address some of the outstanding questions related to the
pathophysiology of CF. It will, perhaps, prove most valuable
for studies of gene or protein therapeutic interventions, in
which efficacy of intervention could not previously be deter-
mined in conventional models because of the absence of lung
disease. The major practical limitation of this animal model is
Figure 6. Measurements of nasal PD. Representative nasal PD tracings (A) in wild-type C57BL/6J and C56BL/6J Cftrm1UNC/Cftrm1UNC mice. 
Amil, addition of 100 mM amiloride; OCl, elimination of luminal Cl2; and UTP, addition of 100 mM UTP. Summary data are shown as 
mean6SEM for 27 wild-type C57BL/6J mice, 11 C57BL/6J Cftrm1UNC/Cftrm1UNC mice, and 7 Cftrm1UNC/Cftrm1UNC mice (B). The C57BL/6J 
Cftrm1UNC/Cftrm1UNC mice have a significantly elevated basal PD relative to wild-type C57BL/6J mice (P , 0.002). The PD response to a Cl2-free 
solution of C57BL/6J Cftrm1UNC(2/2) mice was significantly reduced compared with wild-type C57BL/6J mice (P , 0.05). Both the C57BL/6J 
Cftrm1UNC/Cftrm1UNC and the wild-type C57BL/6J mice differed from the Cftrm1UNC/Cftrm1UNC mice (P , 0.005 and P , 0.002, respectively), in that 
they failed to exhibit a response to treatment with UTP.
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the severity of their gastrointestinal disease, which severely
limits the survival of congenic CF mice and the numbers of an-
imals available for study.
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